Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q3 2023 Earnings Call Transcript
Megan LeDuc: Good evening. I'm Megan LeDuc, Manager of Investor Relations at Ginkgo Bioworks. I'm joined by Jason Kelly, our Co-Founder and CEO; and Mark Dmytruk, our CFO.
Ginkgo Bioworks Holdings Inc. (DNA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Ghisallo Capital Management Michael Germino | 0 | $0 | 0% | |
| 2. | Davidson Kempner Thomas Lenox Kempner | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | ||
| 4. | Trybe Capital Management Jasjit Rekhi | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.28 | 400,000 | Director | 1,731,874 | 2023-05-18 | Filing | |
| $1.28 | 350,000 | Director | 420,921 | 2023-05-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.35 | 37,650 | Large Shareholder, Officer, Director | 12,487,494 | 2023-11-30 | Filing | |
| $1.45 | 37,650 | Large Shareholder, Officer, Director | 12,487,504 | 2023-11-29 | Filing | |
| $1.35 | 100,000 | Officer, Director | 4,694,680 | 2023-11-30 | Filing | |
| $1.45 | 100,000 | Officer, Director | 4,794,680 | 2023-11-29 | Filing | |
| $1.35 | 37,650 | Large Shareholder | 12,487,494 | 2023-11-30 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% |
News See All
15 Best ARK Stocks To Buy Now
Cathie Wood’s flagship ARK Innovation ETF made a roaring comeback earlier this year when investors’ risk appetite increased and growth stocks rebounded.
Top 20 Genomics Companies in the World
In this piece, we will take a look at the top 20 genomics companies in the world.
5 Best High Risk Penny Stocks to Buy Now
Ranking 5th in our list of the best high risk penny stocks is Gossamer Bio, Inc. (NASDAQ:GOSS), a biopharma company working on treatments in immunology, inflammation, and oncology segments.
5 Best Biotech Penny Stocks to Buy Now
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) ranks 5th in our list of the best biotech penny stocks to buy now according to hedge funds. Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q2 2023 Earnings Call Transcript
Anna Marie Wagner: Good evening. I am Anna Marie Wagner, SVP of Corporate Development at Ginkgo Bioworks. I’m joined by Jason Kelly, our Co-Founder and CEO; and Mark Dmytruk, our CFO.
11 Best Medical Stocks Under $10
In this piece, we will take a look at the eleven best medical stocks under $10.
Top 20 Highest Paid CEOs in the World
In this piece, we will take a look at the top twenty highest paid chief executive officers in the world.
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q1 2023 Earnings Call Transcript
Anna Marie Wagner: Good afternoon. I'm Anna Marie Wagner, SVP of Corporate Development at Ginkgo Bioworks. I'm joined by Jason Kelly, our Co-Founder and CEO; and Mark Dmytruk, our CFO.
15 Stocks that will 10x in 5 Years According to the Media
Investing in the stock market can very well be described as reading a crystal ball.
Billionaire Hedge Funds
